Metabolomics of saliva, serum, and urine for pathogenesis, diagnosis, and prognosis in gestational diabetes mellitus
Authors:
Open Access
- 11 December 2025
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 11070
Abstract
Gestational diabetes mellitus (GDM) is a common metabolic disorder in pregnancy, but the underlying mechanism has not been fully clarified. Using metabolomic profiling of second-trimester saliva, serum, and urine, we identify 54 metabolites altered in GDM that converge on key metabolic pathways. Fifty GDM biomarkers independently associated with abnormal maternal glucose and insulin resistance are selected to construct GDM discriminant models (internal test AUC: 0.868; real-world test: 0.796). These GDM biomarkers are also associated with clinical profiles and adverse outcomes, thereby predicting maternal and neonatal risks (internal test AUC: 0.764 and 0.838; real-world test: 0.726 and 0.792, respectively). Eleven GDM biomarkers are already altered in the first trimester, which can be used for the early prediction of GDM (internal test AUC: 0.767; real-world test: 0.744). In this work, changes and interactions of metabolites in saliva, serum, and urine in the second trimester are first identified in GDM, providing insights into its pathogenesis and potential early prediction and prevention strategies.Keywords
This publication has 48 references indexed in Scilit:
- Rapid and Noninvasive Early Detection of Lung Cancer by Integration of Machine Learning and Salivary Metabolic Fingerprints Using MS LOC Platform: A Large‐Scale Multicenter StudyAdvanced Science, 2025
- First-trimester nuclear magnetic resonance–based metabolomic profiling increases the prediction of gestational diabetes mellitusAmerican Journal of Obstetrics and Gynecology, 2024
- Mammalian D-Cysteine controls insulin secretion in the pancreasMolecular Metabolism, 2024
- Establishment of gestational diabetes risk prediction model and clinical verificationJournal of Endocrinological Investigation, 2023
- Metabolomics in gestational diabetes mellitus: A reviewClinica Chimica Acta, 2022
- Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysisEndocrine, 2022
- IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s CriteriaDiabetes Research and Clinical Practice, 2022
- Gestational diabetes mellitus-associated changes in the breast milk metabolome alters the neonatal growth trajectoryClinical Nutrition, 2021
- Perfluorinated polymer modified vertical silicon nanowires as ultra low noise laser desorption ionization substrate for salivary metabolites profilingTalanta, 2021
- Metabolomic profiling in the prediction of gestational diabetes mellitusDiabetologia, 2015